Article Details

Clinical Overview: Teplizumab for Type 1 Diabetes Mellitus - Pharmacy Times

Retrieved on: 2022-12-05 18:49:04

Tags for this article:

Click the tags to see associated articles and topics

Clinical Overview: Teplizumab for Type 1 Diabetes Mellitus - Pharmacy Times. View article details on hiswai:

Excerpt

Teplizumab is a humanized IgG1κ Fc-nonbinding anti-CD3 monoclonal antibody that blocks T cells, preventing them from attacking beta cells.

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up